Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Tilomisole
Подписчиков: 0, рейтинг: 0
Names | |
---|---|
Preferred IUPAC name
[3-(4-Chlorophenyl)[1,3]thiazolo[3,2-a] [1,3]benzimidazol-2-yl]acetic acid | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C17H11ClN2O2S | |
Molar mass | 342.80 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Tilomisole (WY-18,251) is an experimental drug which acts as an immunomodulator and has been studied for the treatment of some forms of cancer.
It can also be seen to contain the arylacetic acid moiety that is endemic to many NSAIDs, e.g. ibufenac.
Endogenous |
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exogenous |
Intracellular (initiation) |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
|
||||||||||||||
Extracellular |
|
||||||||||||||
Unsorted |